JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue

Go back to JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue

Wolfe Research on JPMorgan (JPM): 'we could see any weakness get bought'

July 14, 2026 8:25 AM EDT

Wolfe Research on JPMorgan (NYSE: JPM): 'we could see any weakness get bought'.

The analyst comments "JPM: JPM reported 2Q EPS of $7.70; excluding gains on Visa / other Equity Investments, core EPS was $6.14, handily eclipsing WR / Cons. of $5.50 / $5.56. The beat was driven by better fee income... More

Barclays on JPMorgan (JPM): 'expenses and tax rate were higher than anticipated'

July 14, 2026 8:23 AM EDT

Barclays analyst Jason Goldberg reiterated an Overweight rating and $391.00 price target on JPMorgan (NYSE: JPM).

The analyst comments "EPS beat as fees (trading, IBD) and provision (NPA, NCO lower) were ahead and NII was in-line, though expenses and tax rate were higher than... More

Evercore ISI on JPMorgan (JPM): 'Some focus will be on the factors that brought NIM compression'

July 14, 2026 8:22 AM EDT

Evercore ISI analyst Glenn Schorr reiterated an Outperform rating and $360.00 price target on JPMorgan (NYSE: JPM).

The analyst comments "JPM 2Q26 $6.14 EPS vs. Our/Street of $5.70/$5.56: Big revenue beat (higher than high expectations), modest NII & FICC misses. NII guided up $1.5bn-$2.5bn on growth & rates, while the expense guide... More